Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: '7 xylosyltaxol'

Search results for: '7 xylosyltaxol'

Items 1-10 of 69

Page
per page
  1. ML-7 hydrochloride
    A3626 ML-7 hydrochloride
    Target: Myosin light chain kinases (MLCKs)
    Summary: Myosin light chain kinase inhibitor
      insoluble in EtOH; ≥15.95 mg/mL
  2. 7-Ethoxyresorufin
    B5963 7-Ethoxyresorufin
    Target: Cytochrome P450 (CYP450)
    Summary: Specific subtrate of CYP1A
      Soluble in DMSO
  3. Regorafenib
    A8236 Regorafenib
     4 Citation
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1
      ≥25.04 mg/mL
  4. JLK 6
    A4403 JLK 6
    Summary: γ-secretase inhibitor
      <22.56 mg/mL
  5. AVE 0991
    B1007 AVE 0991
     1 Citation
    Target: Angiotensin AT1 Receptors
    Summary: Agonist of angiotensin-(1-7) receptor
      ≥29.04 mg/mL
  6. SNS-032 (BMS-387032)
    A1980 SNS-032 (BMS-387032)
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK inhibitor
      insoluble in H2O; ≥19.05 mg/mL
  7. PLX-4720
    A3016 PLX-4720
     1 Citation
    Target: Raf
    Summary: BRAF kinase inhibitor
      ≥20.69 mg/mL
  8. Fostriecin sodium salt
    A4536 Fostriecin sodium salt
    Target: PP1|PP2A|Topoisomerases|PP4
    Summary: Antitumor antibiotic
      Soluble in H2O
  9. GDC-0941
    A8210 GDC-0941
     10 Citation
    Target: PI3K
    Summary: PI3K inhibitor,potent and selective
      ≥25.7 mg/mL
  10. GDC-0879
    A5071 GDC-0879
     1 Citation
    Target: Raf
    Summary: B-Raf inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥16.7 mg/mL

Items 1-10 of 69

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
  2. Specificity Selective Remove This Item
  3. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 6item
  2. Apoptosis 3item
  3. Chromatin/Epigenetics 6item
  4. Metabolism 5item
  5. MAPK Signaling 4item
  6. Tyrosine Kinase 12item
  7. DNA Damage/DNA Repair 5item
  8. PI3K/Akt/mTOR Signaling 7item
  9. Microbiology & Virology 2item
  10. Cell Cycle/Checkpoint 4item
  11. Ubiquitination/ Proteasome 6item
  12. JAK/STAT Signaling 1 item
  13. GPCR/G protein 6item
  14. Stem Cell 2item
  15. Membrane Transporter/Ion Channel 3item
  16. Endocrinology and Hormones 1 item
  17. Neuroscience 5item
  18. Others 4item
Reversibility
  1. Reversible 4item
  2. Irreversible 2item
Target
  1. Caspases 2item
  2. Cyclin-Dependent Kinases 4item
  3. Proteasome 3item
  4. Histone Deacetylases (HDACs) 3item
  5. PI3K 3item
  6. Raf 3item
  7. CSF-1R 1 item
  8. FLT3 2item
  9. GSK-3 2item
  10. Factor Xa 1 item
  11. VEGFR 4item
  12. PDGFR 4item
  13. c-Kit 2item
  14. RET 1 item
  15. p38 2item
  16. FGFR 1 item
  17. Deubiquitinating enzymes (DUBs) 1 item
  18. PP1 1 item
  19. PP2A 1 item
  20. MET 1 item
  21. Trk Receptors 1 item
  22. STAT 1 item
  23. Topoisomerases 1 item
  24. Cytochrome P450 (CYP450) 1 item
  25. HMG-CoA Reductases 1 item
  26. c-MET 3item
  27. 5-HT2 Receptors 1 item
  28. DGAT 1 item
  29. Insulin and Insulin-like Receptors 1 item
  30. PARP 1 item
  31. ALK 1 item
  32. Myosin light chain kinases (MLCKs) 1 item
  33. D2 Receptors 1 item
  34. Autophagy 1 item
  35. COX 1 item
  36. Ron 1 item
  37. Synthases/Synthetases 1 item
  38. Histamine H1 Receptors 1 item
  39. Phospholipases 1 item
  40. cAMP 1 item
  41. Sulfonylurea receptors 1 item
  42. Peptidoglycan synthesis 1 item
  43. Nuclear Receptors 1 item
  44. Catechol O-Methyltransferase (COMT) 1 item
  45. Angiotensin AT1 Receptors 1 item
  46. DREADD Ligands 1 item
  47. PP4 1 item
  48. Ub-conjugating enzyme (E2) complex 1 item
  49. P97 ATPase 1 item
  50. ITK 1 item
  51. NUAK 1 item
  52. NOP Receptors 1 item
  53. PRMT 1 item
  54. Serotonin (5-HT) reuptake 1 item
  55. NE 1 item
  56. PIKfyve 1 item
Related Disease
  1. Acute Myelogenous Leukemia 2item
  2. Acute Myeloid Leukemia 1 item
  3. Bladder Cancer 1 item
  4. B-lymphoid Malignancies 1 item
  5. Brain Injuries Studies 1 item
  6. Breast Cancer 7item
  7. Cancer 31item
  8. Chronic Lymphocytic Leukemia 2item
  9. Cocaine-Related Disorders 1 item
  10. Colon Cancer 1 item
  11. Colorectal Cancer 7item
  12. Depression 1 item
  13. Diabetes 2item
  14. Glioblastoma 4item
  15. Glioma 1 item
  16. Hepatocellular Carcinoma 1 item
  17. Lung Cancer 1 item
  18. Lung Carcinoma 1 item
  19. Lymphoma 4item
  20. Mantle Cell Lymphoma 2item
  21. Melanoma 2item
  22. Multiple Myeloma 4item
  23. Myeloma 1 item
  24. Neuroblastoma 2item
  25. Neurocognitive Disorders 1 item
  26. Non-small Cell Lung Cancer 3item
  27. Obsessive-Compulsive Disorder 1 item
  28. Ovarian Cancer 3item
  29. Pancreatic Cancer 2item
  30. Prostate Cancer 1 item
  31. Renal Cancer 1 item
  32. Rheumatoid Arthritis 1 item
  33. Schizophrenia 1 item
  34. Thyroid Cancer 1 item
  35. Type 2 Diabetes 2item